Recent proteomic studies have shown that urinary and serum alpha-1-acid glycoprotein-1 (AGP1), also known as ORM1, have been proposed as prognostic biomarkers for inflammatory diseases such as chronic heart failure (24), some types of cancer (25), and lately for PA (26). This evidence concerns the gene ORM1 and congestive heart failure.